Tenax Therapeutics (TENX) Return on Capital Employed (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.00 |
| Dec 31, 2025 | -1,019.00 |
| Sep 30, 2025 | -1,540.00 |
| Jun 30, 2025 | -643.00 |
| Mar 31, 2025 | -566.00 |
| Dec 31, 2024 | 2,727.00 |
| Sep 30, 2024 | 12,405.00 |
| Jun 30, 2024 | -4,825.00 |
| Mar 31, 2024 | 1,405.00 |
| Dec 31, 2023 | -17,329.00 |
| Sep 30, 2023 | -203.00 |
| Jun 30, 2023 | -4,397.00 |
| Mar 31, 2023 | -41,562.00 |
| Dec 31, 2022 | 141,453.00 |
| Sep 30, 2022 | 23,140.00 |
| Jun 30, 2022 | 71,214.00 |
| Mar 31, 2022 | -130,527.00 |
| Dec 31, 2021 | -128,494.00 |
| Sep 30, 2021 | -47,869.00 |
| Jun 30, 2021 | 48,474.00 |
| Mar 31, 2021 | 55,330.00 |
| Dec 31, 2020 | 29,504.00 |
| Sep 30, 2020 | 8,315.00 |
| Jun 30, 2020 | -182.00 |
| Mar 31, 2020 | -1,807.00 |
| Dec 31, 2019 | -11,191.00 |
| Sep 30, 2019 | -885.00 |
| Jun 30, 2019 | -1,109.00 |
| Mar 31, 2019 | 3,133.00 |
| Dec 31, 2018 | 12,796.00 |
| Sep 30, 2018 | -3,265.00 |
| Jun 30, 2018 | -5,273.00 |
| Mar 31, 2018 | -3,308.00 |
| Dec 31, 2017 | 42,676.00 |
| Sep 30, 2017 | -12,402.00 |
| Jun 30, 2017 | -6,178.00 |
| Mar 31, 2017 | -15,716.00 |
| Dec 31, 2016 | -16,910.00 |
| Apr 30, 2013 | 1,541.00 |
| Jan 31, 2013 | -24,320.00 |
| Oct 31, 2012 | 96,826.00 |
| Jul 31, 2012 | -73,701.00 |
| Apr 30, 2012 | -105,054.00 |
| Jan 31, 2012 | 58,480.00 |
| Oct 31, 2011 | -19,332.00 |